Search results for: Pharmaceutical Industry
Filter search results
New Drugs to Tackle Antimicrobial Resistance: EU Policy Options
1 October 2010
…been de-emphasised by biopharmaceutical companies. Four key sets of factors are identified that provide serious disincentives for R&D. The authors develop a model to assess the push, pull and hybrid…
Forward Together: Complementarity of Public and Charitable Research with Respect to Private Research Spending
9 January 2009
…may be particularly important in the pharmaceutical and biotech sectors because of the characteristics of that R&D, including high uncertainty, high rates of failure and high costs. The study reports…
The Market for Biosimilars: Evolution and Policy Options
1 November 2008
…deter biosimilar entry and reduce long term savings. Outcomes data also are important in helping assess the value for money of second generation biopharmaceutical products as compared to the first…
Vaccination
1 September 1974
…sources of many infections have been eliminated and the resistance of the population to communicable illness has been raised. Pharmaceutical developments since the 1930s have also aided in the reduction…